Dana Hicks

Dana Hicks

Auto-generated profile, based on publicly available information

Dana Hicks

Murdoch University

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2025 in Analytica Chimica Acta
Verified
Journal Article
Open access
DHDana Hicks
Dana Hicks
MRMonique Ryan
Monique Ryan
AAAmira Allahham
Amira Allahham
LBLucy W. Barrett
Lucy W. Barrett
SLSilvia Lee
Silvia Lee
NGNicola Gray
Nicola Gray
Robust tissue pre-treatment and lipid extraction workflows are crucial to metabolic phenotyping studies and accurate interpretation of lipid profiles. Numerous methods for lipid extraction from tissues have been developed, and the choice of technique influences analysis. This study provides a comprehensive evaluation of six liquid-liquid extraction methods (three biphasic and three monophasic) used for lipidomic tissue analysis by liquid chromatography-mass spectrometry. Extraction methods were assessed for their suitability for comprehensive lipid profiling across diverse tissue types: adipose, liver, and heart. These techniques were compared using lyophilised and fresh frozen samples. The study revealed significant differences in the coverage and reliability of lipid species extracted using each technique, dependent on the tissue type. The optimal extraction method for adipose tissue was butanol:methanol (BUME) (3:1) which achieved the highest lipid coverage, yield and reproducibility (886 lipids with a coefficient of variation (CV) < 30 %); methyl tert-butyl ether (MTBE) with ammonium acetate was most effective for liver tissue (707 lipids CV < 30 %) and BUME (1:1) for heart tissue (311 lipids CV < 30 %). These findings showed that the most effective lipid extraction methods are highly tissue-specific, underscoring the critical need for bespoke protocols tailored to each tissue type. The optimised tissue-specific methods were validated using an intervention study in C57BL/6 mice to investigate diet-induced metabolic changes. The results demonstrated distinct discriminating lipid profiles unique to each tissue type, with 374 lipid species from 13 subclasses significantly different between high-fat diet (HFD) and normal diet (ND) in adipose tissue, while 485 lipid species from 17 subclasses were significantly different between HFD and ND in liver tissue. This study presents a new approach to studying lipid profiles derived from diverse tissues that substantially improve comprehensive lipid species' detection sensitivity and reliability. Our systematic evaluation provides evidence that tailored tissue-specific extraction protocols are highly valuable in comprehensive lipidomics studies, offering robust tools for reliably identifying lipid changes and facilitates a deeper understanding of tissue-specific metabolic processes in diverse research and clinical applications.

22 May 2026 in Expert Reviews in Molecular Medicine
Verified
Journal Article
Open access
PDF file
DHDana Hicks
Dana Hicks
LWLuke Whiley
Luke Whiley
Background: Lactosylceramides (LacCers) are glycosphingolipids that play essential roles in physiological and pathological processes across immune, endocrine, and neurological systems, with mechanistic studies demonstrating that LacCers modulate inflammatory signalling, oxidative stress responses, membrane microdomain organisation, and control aspects of mitochondrial function. Historically, LacCers were quantified predominantly as a total lipid subclass, limiting the ability to discern how individual species contribute to biological processes in clinical contexts. Recent advances in mass spectrometry based lipidomics now enable LacCer species to be resolved by acyl-chain length and saturation, offering far greater biochemical and clinical insights. Methods: In this narrative review, we examine evidence from population based lipidomic studies describing how LacCer composition varies across healthy and diseased states. Results: In metabolic and vascular disorders, multiple studies report elevations in specific short- and medium-chain LacCer species, whereas patterns involving longer-chain species appear more heterogeneous. Altered LacCer profiles have also been described in neurodegenerative disease, chronic kidney disease, and cancers, with species-level differences varying by disease-context, tissue type, and analytical platform. Conclusions: Our findings describe disease- and tissue-specific variations in LacCer acyl-chain composition, underscoring the value of species-level resolution for mechanistic understanding and informing the application of LacCer profiles in future biomarker and therapeutic studies.

25 June 2025 in medRxiv
Verified
Preprint
Open access
PDF file
DHDana Hicks
Dana Hicks
AJAnu Joyson
Anu Joyson
NWNatalie Ward
Natalie Ward
BYBu B. Yeap
Bu B. Yeap
GDGirish Dwivedi
Girish Dwivedi
NGNicola Gray
Nicola Gray
Cardiovascular-kidney-metabolic (CKM) syndrome recognises connections among obesity, diabetes, chronic kidney disease, and cardiovascular disease, describing the close metabolic links and shared risk factors including dyslipidemia, hypertension, and metabolic dysfunction. While the concentrations of circulating metabolites have been frequently measured in these varied pathophysiological conditions, the flux of metabolites between and across organs is not easily captured. Arteriovenous sampling provides a transformative approach to metabolite gradient measurements offering new insights into organ-specific regulation of lipid, lipoprotein, and small molecule metabolism. Here, arteriovenous sampling was used to determine organ-specific metabolic differences between the heart and kidney compared with peripheral venous differences. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) and nuclear magnetic resonance (NMR) analysis was performed to assess lipids, lipoproteins and small molecules in peripheral venous, coronary sinus (CS), renal vein and radial artery samples collected from 18 participants with stage 1-2 CKM. Paired arterial-CS and arterial-renal vein gradients revealed significant differences in lipid and lipoprotein metabolism. The heart exhibited net uptake of long-chain fatty acids (e.g., FA(18:0), FA(20:3)) and very-low-density lipoprotein (VLDL) subfractions (e.g., VLFC, VLAB), along with a net release of lysophosphatidylethanolamine (LPE(18:2)). In contrast, the kidney showed net uptake of diacylglycerols (DG), fatty acids (e.g., FA(14:0), FA(16:1)), and lysophospholipids (e.g., LPE(20:4)). Significant differences in glutamine, citric acid, lactic acid, and pyruvic acid gradients between the heart and kidneys were noted, with each analyte showing a net uptake by its respective organ. Our findings highlight the comprehensive changes in organ-specific metabolites and lipids that occur between the heart and kidneys. These data indicate the value of arteriovenous sampling in understanding the metabolic differences between the heart and kidneys, and its potential to explore bidirectional metabolic crosstalk between these organs.

1 September 2025 in American Journal of Physiology-Cell Physiology
Verified
Journal Article
Closed access
JKJunwoo Kim
Junwoo Kim
YMYuben Moodley
Yuben Moodley
NLNick S. R. Lan
Nick S. R. Lan
SWShelley Waters
Shelley Waters
DHDana Hicks
Dana Hicks
GDGirish Dwivedi
Girish Dwivedi
This is the first study to apply MALDI-MSI to characterize the spatial lipidomic landscape of granulomatous inflammation in both a murine sarcoid-like model and a rare human case. Our work reveals distinct yet shared lipidomic profiles in both sarcoid-like animal and human tissues, including region-specific lipid alterations within granulomas. By integrating spatial imaging with lipidomics, this study bridges a critical gap in our understanding of the metabolic and structural composition of granulomatous inflammation.

25 September 2026 in Metabolomics
Verified
Journal Article
Open access
PDF file
HSHarrison Szemray
Harrison Szemray
VNVimalnath Nambiar
Vimalnath Nambiar
DHDana Hicks
Dana Hicks
Samantha LodgeSamantha Lodge
Samantha Lodge
JWJulien Wist
Julien Wist
LWLuke Whiley
Luke Whiley
Introduction: Targeted metabolic phenotyping by liquid chromatography–tandem mass spectrometry (LC-MS/MS) relies on a fragmented toolchain of proprietary vendor formats, manual integration steps, and ad hoc quality-control (QC) scripts, introducing user- and laboratory-level variation that undermines reproducibility and confounds cross-laboratory and retrospective comparison. Objectives: To provide an open-source, R-native workflow for targeted multiple reaction monitoring (MRM/SRM) mass spectrometry data that consolidates vendor file conversion, peak integration, and QC reporting into a single reproducible pipeline while preserving auditable, human-in-the-loop peak review. Methods: MStargetR builds on msConvert and Skyline through three modules: msConvertR (vendor-to-mzML conversion), PeakForgeR (peak boundary optimisation and automated peak integration executed through Skyline), and qcCheckR (normalisation, concentration calculation, signal and batch correction, and reporting). Additionally, MStargetR has a standalone correction module and a Shiny graphical user interface. Third-party tools are pinned in version-controlled Docker images (with Apptainer support for high-performance computing), and each analytical plate emits a fully populated sky document for inspection and reimport. Results: Applied to a published targeted lipidomics dataset of 128 human plasma samples targeting 1,161 lipid species, MStargetR processed all samples end-to-end, recovering all 1,161 targeted lipid features, 949 of which (81.7%) were detected and returned RSD < 30% across replicated long-term reference QCs. Analysis scaled linearly to 4,200 samples, averaging 4.1 s per sample. Conclusion: MStargetR delivers automated batch processing, auditable peak review, and a documented QC layer in a single reproducible pipeline, supporting FAIR-aligned targeted metabolomics.